Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Public ClinicalTrials.gov record NCT02188719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Liver Transplantation (RTB-002)
Study identification
- NCT ID
- NCT02188719
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- Acetaminophen Drug
- Anti-Infective Prophylaxis Drug
- Anti-Thymocyte Globulin - Rabbit Biological
- Blood draws Procedure
- Diphenhydramine Drug
- Everolimus Drug
- Leukapheresis Procedure
- Liver biopsies Procedure
- Liver transplantation Procedure
- Mycophenolate mofetil Drug
- Prednisone Drug
- Tacrolimus Drug
- darTreg Infusion Biological
Drug · Biological · Procedure
Eligibility (public fields only)
- Age range
- 21 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2014
- Primary completion
- Jun 17, 2019
- Completion
- Jun 17, 2019
- Last update posted
- Sep 21, 2020
2014 – 2019
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Northwestern University | Chicago | Illinois | 55905 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02188719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2020 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02188719 live on ClinicalTrials.gov.